On September 9, 2021, the U.S. Department of Health and Human Resources (HHS) Assitant Secretary for Planning and Evauation (ASPE) published this report in response to the Executive Order on competition in the American economy concerning a comprehensive plan for addressing high drug prices. The Report presents principles for equitable drug pricing reform through competition, innovation, and transparency; describes promising legislative approaches; and summarizes actions already underway or under consideration across HHS . . .
Industry Resource |